Skip to Main Content

Paper Details

Subcutaneous Infliximab Monotherapy Versus Combination Therapy with Immunosuppressants in Inflammatory Bowel Disease: A Post Hoc Analysis of a Randomised Clinical Trial.
0
2023
ADA, CT-P13, Crohn's disease, IBD, Inflammatory Bowel Disease, Infliximab, inflammatory bowel disease, infliximab, patients, ulcerative colitis
Author NameAffiliation
Stefan SchreiberUniversity Hospital Schleswig-Holstein
  • 1 - 1

Datasets

Release 1.2